Optum and Express Scripts want opioid special master removed after reply-all-email incident

Optum and Express Scripts want opioid special master removed after reply-all-email incident

Used blister packs containing medicines, tablets and pills are seen in this illustration taken June 30, 2018. REUTERS/Russell Boyce/Illustration Acquire License Rights Summary Businesses Law firms First reference trials currently being selected in opioid lawsuits against pharmacy benefit managers Firms say appearance of bias means special master can’t handle their cases Oct. 31 (Reuters) – …

Read more

Legal abortions did not decline in the first year after Dobbs. Expanded out-of-state access and virtual care have played a role

Legal abortions did not decline in the first year after Dobbs.  Expanded out-of-state access and virtual care have played a role

The number of legal abortions has increased nationwide, a year after the U.S. Supreme Court ended the constitutional right to abortion. This is despite the fact that many states ban abortion altogether or restrict access to abortion after six weeks. The latest WeCount report from the Society of Family Plannings finds that there were nearly …

Read more

Demand for weight-loss drugs fuels global rise in counterfeits

Demand for weight-loss drugs fuels global rise in counterfeits

[1/2]Boxes of Ozempic, an injectable semaglutide drug used to treat type 2 diabetes manufactured by Novo Nordisk, are seen at a Rock Canyon pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File photo acquire licensing rights Oct 20 (Reuters) – Extraordinary demand for Novo Nordisks (NOVOb.CO) Ozempic and other drugs used for weight loss …

Read more

Novo Nordisk warns of online offers against fake Ozempic and Wegovy on the rise

Novo Nordisk warns of online offers against fake Ozempic and Wegovy on the rise

[1/2]A 0.25 mg injection pen of Novo Nordisk’s weight loss drug Wegovy is shown in this illustration in Oslo, Norway September 1, 2023. REUTERS/Victoria Klesty/Illustration/File photo acquire license rights Oct 12 (Reuters) – Novo Nordisk (NOVOb.CO) warned on Thursday of a surge in counterfeit versions of its weight loss drug Wegovy and diabetes drug Ozempic …

Read more